General discussion, page-7732

Hey Chaya,

So good to hear you've contacted Joel and are up in arms about the 'piece' that aired.
One has to consider the distinct possibility, and even likelihood, that it was a 'hit' piece. Common phenomenon, and the timing is of special interest of course. IHL is taking oxygen from a number of other less worthy stocks in the space right now, and the end of that is far from in sight. Any number of competitors would gain from trying to slow that ascent. Not to name names, but with the recent announcement of NASDAQ listing plans by a cannabis company with shady management and a third rate psychedelic aspiration... that's where I would be looking first for a culprit.

Anyway, they can run but they can't hide. IHL's IP, strong progress across their drug development programs, and stellar management will speak for themselves and exposure to the US market will drown out any petty BS kicked up by competitors.